Journal of Diabetes and Its Complications

Article	Citations
The association between age at diagnosis of diabetes and development of diabetic retinopathy and assessment of healthcare access as an effect modifier	96
Letter to “Impact of remnant cholesterol and triglycerides on diabetes foot and disease in type 1 diabetes: A propensity score-matched case-control study”	61
Assessing the influence of rural residence and economic distress on lower extremity risk stratification among diabetic foot ulcer patients utilizing the Wound, Ischemia, and Foot Infection (WIfI) clas	60
Changes in cardiac and vascular haemodynamics as potential mediators of improvements in cardiovascular and kidney outcomes with empagliflozin in type 2 diabetes	57
The cardiovascular–kidney–metabolic staging in type 2 diabetes: the clock starts ticking early	51
Effect of fixed-dose combination of insulin degludec and liraglutide on apoB-containing lipoprotein subclasses and HDL lipidome in type 2 diabetes	44
Protective effect of evolocumab on Müller cells in the rat retina under hyperglycaemic and hypoxic conditions	42
Atypical complications and co-morbidities of type 1 diabetes in young adults	42
Prognostic value of insulin resistance and hyperglycemia biomarkers for long-term risks of cardiometabolic outcomes	41
Individual and joint effects of diabetes and depression on incident cardiovascular diseases and all-cause mortality: Results from a population-based cohort study	37
Comparative analysis of the therapeutic effects of pregabalin, gabapentin, and duloxetine in diabetic peripheral neuropathy: A retrospective study	36
Non-alcoholic fatty liver disease and sarcopenia is associated with the risk of albuminuria independent of insulin resistance, and obesity	35
Effects of moderate-intensity aerobic training on cardiac structure and function in type 2 mellitus diabetic rats: Based on echocardiography and speckle tracking	34
Effect of new glucose-lowering drugs on stroke in patients with type 2 diabetes: A systematic review and Meta-analysis	34
A real-world experience with ranibizumab 0.5 mg initial intensive treatment for diabetic macular edema: 24-week outcomes of the RISING-K study	33
Is subclinical cardiovascular disease linked with periodontal disease in diabetic and non-diabetic subjects?	32
Contents/Barcode	30
Association of continuous subcutaneous insulin therapy and diabetic retinopathy in type 1 diabetes: A national cohort study	29
The correlation between patients with type 2 diabetes mellitus and chronic microvascular complications during the glucose peak time	28
The epidemiology of ketosis and low bicarbonate concentration in inpatients treated with sodium-glucose linked cotransporter inhibitors or dipeptidyl peptidase-4 inhibitors	27
Corrigendum to “The PanGut-study: Evoked potentials following rectal balloon distention, a way of evaluating diabetic autonomic neuropathy in the gut?” [J. Diabetes Complicat., Volume 37, Issue 5, May	27
Nonlinear association of the hemoglobin glycation index with all-cause and cardiovascular mortality: A community-based cohort study	26
Echocardiographic evaluation of the effect of dapagliflozin on epicardial adipose tissue and left ventricular systolic function in type 2 diabetes mellitus	25
Multidisciplinary management of diabetic foot infection associated with improved 8-year overall survival	25
Relation of coronary calcium scoring with cardiovascular events in patients with diabetes: The CLARIFY Registry	24

Pericardial fat pad detected on chest X-ray is closely associated with metabolic dysfunction-associated steatotic liver disease and visceral fat accumulation in patients with type 2 diabetes	22
The miR-200 family in type 2 diabetes: therapeutic and biomarker perspectives	21
Serum Isthmin-1 is negatively correlated with HDL-C in type 2 diabetes mellitus	21
Methylglyoxal induces death in human brain neuronal cells (SH-SY5Y), prevented by metformin and dapagliflozin	21
Short-term effects of low-dose tirzepatide on lipid profile, glucose homeostasis and hepatic steatosis index in adults with obesity, but without diabetes mellitus: a prospective observational study	20
Effect of the first and second COVID-19 associated lockdown on the metabolic control of patients with type 2 diabetes in Greece	19
Association of matrix metalloproteinase-10 levels and genetic variant rs17860955 with severe vascular complications in patients with type 1 diabetes: prospective cohort	19
Contents/Barcode	19
A comparative analysis of cost-utility: Chiglitazar vs. sitagliptin in patients with type 2 diabetes in China	18
The role of oral alpha-lipoic acid as an adjuvant antioxidant therapy in diabetic nephropathy among children and adolescents with type 1 diabetes: a randomized controlled trial	18
Circulating proteomic markers are associated with measures of small and large fiber neuropathy and symptoms in type 2 diabetes	17
Association of insomnia with incident chronic cognitive impairment in older adults with type 2 diabetes mellitus: A prospective study of the Hong Kong Diabetes Register	17
Factors associated with adherence or nonadherence to insulin therapy among adults with type 2 diabetes mellitus: A scoping review	17
Cytokine gene variants of TNF-α and IL-10 in the propensity of type 2 diabetes in south Indian population	17
Heterogeneity of treatment effects of glucose-lowering drug classes for type 2 diabetes: LEGEND-T2DM network real-world evidence	16
Effect of dapagliflozin on liver and pancreatic fat in patients with type 2 diabetes and non-alcoholic fatty liver disease	16
Growth differentiation factor-15: A marker for diabetic kidney disease in patients with metabolic-associated fatty liver disease	16
Association between first-line monotherapy with metformin and the risk of atrial fibrillation (AMRAF) in patients with type 2 diabetes	16
Inflammation level in type 2 diabetes is associated with dietary advanced glycation end products, Mediterranean diet adherence and oxidative balance score: A pathway analysis	16
The effects of SGLT2 inhibitors and GLP-1 receptor agonists on the triglyceride to HDL cholesterol ratio and the triglyceride-glucose index in patients with type 2 diabetes	16
Contents/Barcode	16
Gestational diabetes mellitus and the subsequent risk of chronic kidney disease: A systematic review and meta-analysis	15
Health status in stage B heart failure from diabetic cardiomyopathy baseline results from ARISE-HF	15
The effect of dapagliflozin therapy on ventricular repolarization parameters in electrocardiography in patients with diabetic cardiovascular disease	15
Neuroinflammation and osteomyelitis in adults with Type 2 diabetes mellitus and peripheral neuropathy without and with foot lesions. What comes first?	15
The PanGut-study: Evoked potentials following rectal balloon distention, a way of evaluating diabetic autonomic neuropathy in the gut?	15
Response to the letter to the editor	15
Circulating soluble CD163 as a potential biomarker of diabetes complications	15
Highlighting the complex relationship between diabetes, renal function and bone health	15
Contents/Barcode	15
Elastographic parameters of liver steatosis and fibrosis predict independently the risk of incident chronic kidney disease and acute myocardial infarction in patients with type 2 diabetes mellitus	14
Outcomes associated with a variable rate insulin infusion diabetic ketoacidosis protocol	14
Diabetic ketoacidosis and hyperosmolar hyperglycemic state in type 2 diabetes patients with severe kidney disease: a 7-year retrospective analysis	14
Semaglutide, central retinal thickness and continuous glucose monitoring in persons with type 2 diabetes: A post-hoc analysis from a randomised trial	14
Diabetes and the treatment of ischemic stroke	14
Reduced skeletal muscle mass to visceral fat area ratio is independently associated with reduced cognitive function in type 2 diabetes mellitus	14
Impact of SGLT2 inhibitors on the mechanisms of myocardial dysfunction in type 2 diabetes: A prospective non-randomized observational study in patients with type 2 diabetes mellitus without overt hear	13
Diabetic neuropathy in adolescents and young adults: The need for early detection and improved understanding	13
Associations of peroxisome proliferator-activated receptor-γ Pro12Ala polymorphism with non-alcoholic fatty liver disease: A meta-analysis	13
Role of profilin-1 in vasculopathy induced by advanced glycation end products (AGEs)	13
Effectiveness of adding glucagon-like peptide-1 receptor agonist on diabetes complications and mortality among basal insulin-treated people with type 2 diabetes: A real-world Korean study	13
PINK1 and oxidative stress in lean and obese patients with type 2 diabetes mellitus	13
Clinical features and outcomes of patients diagnosed with diabetic ketoacidosis (DKA) who were hospitalized for conditions outside of internal medicine	13
Stepwise cardiovascular risk stratification in patients with type 2 diabetes based on coronary CT assessment	13
Transient albuminuria in the setting of short-term severe hyperglycemia in type 1 diabetes	13
Achievement of low-density lipoprotein cholesterol goals in patients with diabetes-related foot ulceration	13
The effect of bariatric surgery on diabetes related foot complications among patients with type 2 diabetes: A systematic review	13
Contents/Barcode	13
Implementation of evidence-based foot screening in people with diabetes: A scoping review	13
Inhibition of IL-33 signaling ameliorate hepatic fibrosis with decreasing MCP-1 in a mouse model of diabetes and non-alcoholic steatohepatitis; comparison for luseogliflozin, an SGLT2 inhibitor	12

The effect of SGLT2 inhibitors, GLP1 agonists, and their sequential combination on cardiometabolic parameters: A randomized, prospective, intervention study	12
Correlation of cerebral small vessel disease burden with outcome after lower extremity amputation	12
The legacy effect in early-stage diabetes: Don't stay by me, cardiovascular disease!	12
Soluble Tumor Necrosis Factor Receptors (sTNFRs) as biomarkers for Diabetic Kidney Disease	12
Lower extremity amputation rates in patients with chronic kidney disease: A database study comparing patients with and without diabetes mellitus	12
Von Willebrand factor hyperactivity affects the outcome of lower limb revascularization in subjects with type 2 diabetes mellitus complicated by diabetic foot vasculopathy: An observational pilot stud	12
Contents/Barcode	12
Increased intracellular miR-142 in adults with Type 1 diabetes	12
Contemporary prevalence of diabetic neuropathies in individuals with type 1 and type 2 diabetes in a Danish tertiary outpatient clinic	12
Risk factors and serum amino acid metabolic profiles of patients with type 1 diabetes and concomitant mild cognitive impairment: A cross-sectional study	12
Effects of semaglutide and empagliflozin on oxygenation, vascular autoregulation, and central thickness of the retina in people with type 2 diabetes: A prespecified secondary analysis of a randomised	12
Associations of three diagnostic glycemic measures with all-cause and cardiovascular mortality in people not on antidiabetic medications: A prospective cohort study	12
Diabetic ketosis vs ketoacidosis as initial presentation of pediatric type 1 diabetes mellitus. Associated features and rate of progression during the first two years after diagnosis	12
The effect of vitamin D supplementation on cardiovascular risk in patients with prediabetes: A secondary analysis of the D2d study	11
Letter to the editor regarding “High rate of complications in a real-world cohort of youth with T2D: a multicenter analysis”	11
Relationship between adiponectin and muscle mass in patients with metabolic syndrome and obesity	11
Systemic and ocular outcomes in patients with young-onset type 2 diabetes	11
Understanding the mechanisms mediating cardio-renal benefit of empagliflozin in type 2 diabetes mellitus	11
The association of glucose control on in-hospital mortality in the cardiac intensive care unit	11
Associations of modifiable lifestyle and clinical factors with cognitive function in adults with type 2 diabetes	11
Unmet needs and opportunities for optimal management of patients with type 2 diabetes and chronic kidney disease	11
High fat-induced the upregulation of LOX-1 in RF/6A cells under high glucose condition	11
Prognostic importance of baseline and changes in serum uric acid for macro/microvascular and mortality outcomes in individuals with type 2 diabetes: The Rio de Janeiro type 2 diabetes cohort	11
Body-weight functional exercise promotes greater and safer blood glucose reduction compared to aerobic and strength exercises in type 1 diabetics: a randomised crossover study	11
Prevalence of cardiovascular and renal comorbidities among patients with type 2 diabetes routinely treated in the primary care setting in Greece: An epidemiological study (the RECARDIA study)	11
Association between extrapolated time in range and large for gestational age infants in pregnant women with type 1 diabetes	10
Contents/Barcode	10
Relationship between relative fat mass and coronary artery calcification in patients with type 2 diabetes	10
Urinary A- and C-megalin predict progression of diabetic kidney disease: an exploratory retrospective cohort study	10
Efficacy of levocetirizine in reducing albuminuria and inflammatory biomarkers in patients with diabetic kidney disease: A randomized controlled trial	10
Protein kinase C: A potential therapeutic target for endothelial dysfunction in diabetes	10
Variability in the urinary albumin-to-creatinine ratio predicts mortality in patients with type 2 diabetes	10
Contents/Barcode	10
The anti-inflammatory agent 5-ASA reduces the level of specific tsRNAs in sperm cells of high-fat fed C57BL/6J mouse sires and improves glucose tolerance in female offspring	10
Beyond pounds: What else could be lost?	10
Disease-modifying therapies for diabetic peripheral neuropathy: A systematic review and meta-analysis of randomized controlled trials	10
Time in range is associated with less hypoglycemia fear and higher diabetes technology acceptance in adults with well-controlled T1D	10
Diabetes mellitus therapy in the light of oxidative stress and cardiovascular complications	10
Impaired cerebral hemodynamics and oxygenation in type 2 diabetes: insights into insulin resistance and hyperglycemia effects	10
Pioglitazone increases risk of ischemic heart disease in patients with type 2 diabetes receiving insulin	10
Efficacy and safety of sodium glucose cotransporter 2 inhibitors plus standard care in diabetic kidney disease: A systematic review and meta-analysis	9
Association between Mediterranean diet adherence and peripheral artery disease in type 2 diabetes mellitus: An observational study	9
Predicting the occurrence of DKA following sodium glucose co-transporter-2 inhibitors: An international cohort study	9
Muscle mitochondrial function is impaired in adults with type 1 diabetes	9
Influence of type 2 diabetes mellitus on mortality in women with breast cancer: A matched case-control study	9
Gender difference in association between diabetes mellitus and all-cause mortality in atrial fibrillation patients	9
Impact of Glucagon-like peptide 1 receptor agonists on peripheral arterial disease in people with diabetes mellitus: A narrative review	9
Effects of probiotics and fibers on markers of nephropathy, inflammation, intestinal barrier dysfunction and endothelial dysfunction in individuals with type 1 diabetes and albuminuria. The ProFOS Stu	9
Contents/Barcode	9
Predictors of liver fibrosis progression in cohort of type 2 diabetes mellitus patients with MASLD	9
The handgrip test – A historical test for diabetic autonomic neuropathy or a marker of something else?	9
Fatty acid binding protein 1 (FABP1) and fatty acid binding protein 2 (FABP2) as a link between diabetic nephropathy and subclinical atherosclerosis in children and adolescents with type 1 diabetes	9
Serum visfatin levels are positively correlated with dietary carbohydrate and polyunsaturated fatty acid intakes in type 2 diabetes mellitus patients	9
Cardiovascular events after a dramatic reduction of HbA1c in hospitalized subjects with type 2 diabetes and high long-term glucose exposure	9
Characterizing the relationship between social determinants of health and risk of albuminuria among children with type 1 diabetes	9
Progress in the treatment of vascular complications in type 2 diabetes by finerenone in combination with RAS inhibitors/SGLT-2i	9
Diagnosis, management and impact of painful diabetic peripheral neuropathy: A patient survey in four European countries	8
Effect of prior gestational diabetes on the risk of cardiovascular disease and death in women with type 2 diabetes: The Fremantle Diabetes Study Phase II	8
Gestational diabetes mellitus and hypertensive disorder of pregnancy play as spouse-pair risk factors of diabetes and hypertension: Insights from Tehran Lipid and Glucose Study	8
Contents/Barcode	8
Contents/Barcode	8
Impact of visit-to-visit glycated hemoglobin variability on diabetes distress and its subscales	8
Slowly progressive subtype of childhood-onset type 1 diabetes as a high-risk factor for end-stage renal disease: A cohort study in Japan	8
Uric acid in diabetic microvascular complications: Mechanisms and therapy	8
Kidney fat by magnetic resonance spectroscopy in type 2 diabetes with chronic kidney disease	8
All-cause mortality and factors associated with it in Finnish patients with type 1 diabetes	8
The role of circRNA in insulin resistance and its progression induced by adipose inflammation	8
The association of insulin responses and insulin sensitivity with cognition in adults with pre-diabetes: The Diabetes Prevention Program Outcomes Study	8
Quantitative assessment of structural and functional changes in the carotid artery as vascular markers of gestational diabetes mellitus	8
Sleep and eating patterns in individuals with gestational diabetes: associations with daily overnight and morning glucose using continuous glucose monitoring	8
Age different effects of SGLT2 inhibitors on body composition in individuals with type 2 diabetes: A retrospective cohort study	8
Long-term effects of l-serine supplementation upon a mouse model of diabetic neuropathy	8
High risk, low evidence: Need for more research on lipid-lowering therapies for people with type 1 diabetes	8
Type 2 diabetes mellitus in obesity promotes prolongation of cardiomyocyte contractile function, impaired Ca2+ handling and protein carbonylation damage	8
A comparative study of the relationship between time in range assessed by self-monitoring of blood glucose and continuous glucose monitoring with microalbuminuria outcome, HOMA-IR and HOMA-β test	8
The effect of continuous glucose monitoring-guided glycemic control on progression of coronary atherosclerosis in type 2 diabetic patients with coronary artery disease: The OPTIMAL randomized clinical	8
Finerenone increases the likelihood of improved KDIGO risk category in patients with CKD and type 2 diabetes: An analysis from FIDELITY	8
Serum analysis of type 2 diabetes mellitus patients with low, moderate, and high risk of diabetic kidney disease using LC-MS metabolomics approach	8
Antioxidant effects of a novel pioglitazone analogue (PA9) in a rat model of diabetes: Modulation of redox homeostasis and preservation of tissue architecture	7
Long term risk of heart failure in individuals with childhood-onset type 1 diabetes	7

Relationship between body fat and cognitive function in individuals with diabetes mellitus	7
The role of atherogenic lipoproteins in diabetes: Molecular aspects and clinical significance	7
GLP-1 and dual GIP/GLP-1 receptor agonists in overweight/obese patients for atherosclerotic cardiovascular disease prevention: Where are we now?	7
Cost effectiveness of topical wound oxygen therapy for chronic diabetic foot ulcers	7
Prediction of worsening of renal function by the combination of an initial decline in renal function and blood pressure-lowering effect after renin–angiotensin system blockade in patients with type 2	7
Increase in hypoglycaemia and hyperglycaemia in people with diabetes admitted to hospital during COVID-19 pandemic	7
Dipeptidyl peptidase-4 inhibitors and diabetic retinopathy in type 2 diabetes: A network meta-analysis of randomized clinical trials	7
Duration of diabetes, glycemic control, and low heart rate variability: The Atherosclerosis Risk in Communities (ARIC) study	7
Contents/Barcode	7
Left ventricular longitudinal systolic dysfunction in children with type 1 diabetes mellitus: A systematic review and meta-analysis	7
Low imaging-detected muscle mass as a prognostic factor for overall and amputation-free survival in patients undergoing lower extremity amputation	7
Association of peripheral neuropathy with subclinical left ventricular dysfunction in patients with type 2 diabetes	7
Urogenital side effects in male subjects with type 2 diabetes treated with SGLT-2 inhibitors: A single centre, longitudinal observation	7
“It changed everything we do”: A mixed methods study of youth and parent experiences with a pilot exercise education intervention following new diagnosis of type 1 diabetes	7
Circulating CD31+ Angiogenic T cells are reduced in prediabetes and increase with exercise training	7
DNA repair and inflammatory response genes play a central role in protecting patients with long-standing type 1 diabetes from vascular complications	7
Diabetes distress in a Medicaid sample: The role of psychosocial and health-related factors	7
Analysis of the therapeutic potential of miR-124 and miR-16 in non-alcoholic fatty liver disease	7
Bone mineral density and the risk of kidney disease in patients with type 1 diabetes	7
Soluble urokinase plasminogen activator receptor, platelet aggregation, and carotid plaque thickness in diabetes: A cross-sectional analysis	7
Contents/Barcode	7
Obesity and its management in primary care setting	7
Risk factors at admission of in-hospital dysglycemia, mortality, and readmissions in patients with type 2 diabetes and pneumonia	7
Increased skeletal muscle mass index was involved in glycemic efficacy following diabetes treatment, and changes in fat mass index correlated with the changes in the lipid ratio in type 2 diabetes	7
How to evaluate over 60 million blood glucose data — The design of the MÉRY Diabetes Database	7
Prediction of pre-diabetes and type 2 diabetes nine years postpartum using serum metabolome in pregnant women with gestational diabetes requiring pharmacological treatment	6
Roles and mechanisms of umbilical cord mesenchymal stem cells in the treatment of diabetic foot: A review of preclinical and clinical studies	6
Assessing the impact of dysphagia on quality of life and determining SWAL-QOL cut-off scores in diabetes mellitus patients: a data mining approach	6
Letter to the Editor “The role of artificial intelligence in diabetic retinopathy screening in type 1 diabetes: A systematic review”	6
Effect of semaglutide versus other glucagon-like peptide-1 receptor agonists on cardio-metabolic risk factors in patients with type 2 diabetes: A systematic review and meta-analysis of head-to-head, p	6
Type 2 diabetes and cardiovascular conditions prediction in individuals with metabolic syndrome-associated lipoprotein lipase gene (LPL) single nucleotide polymorphisms (SNPs)	6
The optimal dose of metformin to control conversion to diabetes in patients with prediabetes: A meta-analysis	6
Effects of high estimated glomerular filtration rate on kidney prognosis in individuals with type 2 diabetes	6
Impact of gestational and type 2 diabetes on fetal endothelial cell miRNA expression	6
Longitudinal bidirectional associations between diabetic retinopathy and diagnosed depression: Results from a Danish nationwide registry-based cohort study	6
Role of arterial stiffness and endothelial dysfunction on lower limb performance in older adults with type 2 diabetes: A cross-sectional study	6
PUFA treatment in patients with gestational diabetes mellitus: Lights and shadows	6
Contents/Barcode	6
Reversal of diabetic retinopathy in two patients following the use of physiologic insulin Resensitization	6
Clinical and pathological characteristics of DKD patients with early-onset type 2 diabetes	6
Evaluation of IDx-DR software for diabetic retinopathy screening in outpatient clinics: Efficacy, safety, and feasibility in a real-world setting	6
Impact of aerobic exercise on cardiometabolic health in patients with diabesity: A systematic review and meta-analysis of randomized controlled trials	6
Novel gene-based therapeutic approaches for the management of hepatic complications in diabetes: Reviewing recent advances	6
Close relationship between high HbA1c levels and methemoglobin generation in human erythrocytes: The enhancement of oxidative stress in the process	6
Effects of advanced glycation end-products, diabetes and metformin on the osteoblastic transdifferentiation capacity of vascular smooth muscle cells: In vivo and in vitro studies	6
An online tool using clinical factors to estimate the probability of partial clinical remission of adult-onset Type 1 diabetes	6
Autologous platelet-rich plasma (APRP) in diabetes foot disease: a meta-analysis	6
Associations of apolipoproteinA1, high density lipoprotein cholesterol with hemoglobin glycation index and triglyceride-glucose index in Chinese adults with coronary artery disease	6
Insulin settings and their association with time in range in patients with type 1 diabetes users of predictive low glucose suspend (PLGS) augmented insulin pumps in Santiago, Chile	6
GLP-1 receptor agonists and MASLD in diabetes: A promising path?	6
Design and rationale of the myocardial infarction and new treatment with metformin study (MIMET) - Study protocol for a registry-based randomised clinical trial	6
Influence of glucagon-like peptide-1 receptor agonists on fat accumulation in patients with diabetes mellitus and non-alcoholic fatty liver disease or obesity: A systematic review and meta-analysis of	6
Current primary care approaches to diabetic foot prevention and treatment	6
Atherogenic markers and 1-year amputation risk in adults with diabetic foot in a tertiary level hospital: A retrospective cohort study	6
A national quality survey of in-patient diabetic foot care calls for centralizing care and improving patient communication	6
Exploring the antioxidant properties of semaglutide: A comprehensive review	6
The role of hyperbaric oxygen therapy in the treatment of diabetic foot ulcers - A literature review	6
Association between remnant cholesterol level and severity of chronic kidney disease in patients with type 2 diabetes	6
Exploring the societal cost of major lower limb amputations in patients with type 2 diabetes – A nation-wide and matched register study using difference in difference analysis	6
Ezetimibe attenuates diabetic retinopathy via NRF2-mediated suppression of inflammation and oxidative stress	5
The role of VCAM-1 in diabetic retinopathy: A systematic review and meta-analysis	5
Contents/Barcode	5
The importance of arterial stiffness in pediatric patients with type 1 diabetes mellitus: What's new?	5
Emerging treatment strategies for polycystic ovary syndrome women with obesity: Focus on glucagon-like peptide-1 receptor agonists	5
Real-world initiation of continuous glucose monitoring (CGM) in adults with type 1 diabetes leads to increased body mass index - A brief report from IMI-SOPHIA study	5
The correlation between visceral fat/subcutaneous fat area ratio and monocyte/high-density lipoprotein ratio in patients with type 2 diabetes mellitus and albuminuria	5
The association between reversion of prediabetes and incident cardiometabolic disease and mortality: A systematic review and meta-analysis	5
Regulation of glucose transporter-4 intervention with S. saman leaves extract in streptozotocin-induced diabetic rats	5
Artificial sweeteners and Type 2 Diabetes Mellitus: A review of current developments and future research directions	5
Frontiers in diabetic retinal disease	5
Sodium–glucose cotransporter 2 inhibitors as adjunct therapy for type 1 diabetes and the benefit on cardiovascular and renal disease evaluated by Steno risk engines	5
Correlation between lipoprotein-associated phospholipase A2 and diabetic peripheral neuropathy in patients with type 2 diabetes mellitus: A cross-sectional study	5
From static lipids to dynamic risk: The role of atherogenic index of plasma in prediabetes	5
Contents/Barcode	5
A comprehensive analysis of diabetic patient data before and during the COVID-19 pandemic – Lessons from the MÉRY diabetes database (MDD)	5
Letter to the Editor “Glucagon-like Peptide-1 receptor agonists versus dipeptidyl-peptidase 4 inhibitors in advanced chronic kidney disease and end stage kidney disease: Real world effectiveness and p	5
Risk assessment modeling for diabetes-related lower extremity amputation using socioeconomic and behavioral health indicators	5
Diabetic macular edema: Variations in observations with intensive treatment optimizing glycemia	5
GLP-1 receptor agonists and SGLT2 inhibitors: The need to shed light on their safety risks real dimension and possible mechanisms	5
Contents/Barcode	5
Insulin combined with N-acetylcysteine attenuates type 1 diabetes-induced splenic inflammatory injury in canines by inhibiting the MAPKs-NF-κB signaling pathway and pyroptosis	5
Peri-coronary inflammation and coronary microcalcification activity in subjects with diabetes mellitus; a cross-sectional analysis	5
A community health worker led diabetes self-management education program: Reducing patient and system burden	5
Response to rebuttal	5
Dipeptidyl peptidase-4 inhibitor-related renal disease	5
Effect of lixisenatide on liquid gastric emptying in type 2 diabetes – Implications for the use of GLP-1 receptor agonists before procedures	5
“Predicting diabetic kidney disease in youth with type 1 diabetes: Insights from genetic risk assessment”	5
Data-driven subtypes of newly diagnosed youth-onset type 2 diabetes in the USA	5
Contents/Barcode	5
Global comparison of the effect of non-pharmacological interventions on glycemic control in patients with type 2 diabetes: A network meta-analysis from 107 randomized controlled trials	5
Tirzepatide ameliorates eating behaviors regardless of prior exposure to glucagon-like peptide receptor agonists in Japanese patients with type 2 diabetes mellitus	5
ORal anticoaGulants in diAbetic and Nondiabetic patients with nOn-valvular atrial fibrillatioN (ORGANON)	5
Environmental exposures and blood pressure in adolescents and adults in the T1D exchange clinic registry	5
Contents/Barcode	4
Factors contributing to diabetic ketoacidosis readmission in hospital settings in the United States: A scoping review	4